BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Bordeaux Neurocampus - ECPv4.9.10//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Bordeaux Neurocampus
X-ORIGINAL-URL:https://www.bordeaux-neurocampus.fr/en/
X-WR-CALDESC:Events for Bordeaux Neurocampus
BEGIN:VTIMEZONE
TZID:Europe/Paris
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20241027T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/Paris:20241128T140000
DTEND;TZID=Europe/Paris:20241128T140000
DTSTAMP:20260517T223835
CREATED:20241115T115750Z
LAST-MODIFIED:20241125T145338Z
UID:177673-1732802400-1732802400@www.bordeaux-neurocampus.fr
SUMMARY:Thesis defense - Jeflie Tournezy
DESCRIPTION:Venue: Salle de conférence Neurocentre Magendie \n\nDefense in french \nJeflie Tournezy\nTeam: Oliet\, Neurocentre Magendie \nThesis supervisor: Stéphane Chevallier \nTitle\nTherapeutic effects of the Borna virus X protein in SOD1G93A mice \nAbstrac\nToday\, Amyotrophic Lateral Sclerosis (ALS) remains an incurable disease for which therapeutic trials have been unsuccessful. It is therefore essential to propose new therapeutic approaches that would slow the progression of the disease and prolong patient survival. \nAmong the pathophysiological characteristics described\, mitochondrial dysfunctions are one of the earliest events and could be the origin of the progressive loss of motor neurons. Restoring mitochondrial functions could therefore constitute a therapeutic area of interest to develop new therapies against this disease. \nWith this in mind\, we were interested in the X protein of the Bornavirus (BDV for Borna Disease Virus). When it targets mitochondria\, the X protein inhibits the apoptosis of neurons and protects them from degeneration in an animal model of Parkinson’s disease (Szelechowski et al.\, 2014). This neuroprotective action of the X protein resides in its last 29 carboxy-terminal amino acids which constitute the PX3 peptide. In addition\, a modification to increase the mitochondrial localization of the protein X (XA4 protein) has shown improved neuroprotective effects in vitro. \nThis thesis aimed to propose a new preclinical therapeutic approach\, consisting in protecting motor neurons by using the neuroprotective properties of the Bornavirus X protein. \nFirst\, we tested the neuroprotective effects of the X protein and its derived peptide PX3 in a well-characterized model of ALS\, the SOD1G93A mice. Administration of the PX3 intranasally and the X intramuscularly via a viral vector (CAV2-X) slowed the progression of the disease and increased the survival of lumbar motor neurons. However\, this treatment did not increase the life expectancy of the mice. \nThen\, we used adeno-associated viruses (AAV) as gene transfer tools. More specifically\, we used AAV serotype 10 (AAV10) to administer the gene encoding the X protein (AAV10-X) or its modified form\, the XA4 protein (AAV10-XA4) to SOD1G93A mice. We evaluated the effects of these treatments on motor performances\, life span\, denervation of the neuromuscular junction\, and preservation of lumbar and phrenic motor neurons (motor neurons innervating the diaphragm). \nOur results show that the X and XA4 proteins slowed the degeneration of lumbar motor neurons. Furthermore\, while the X protein delayed the onset of motor deficits\, the XA4 protein extended the life expectancy of the animals. The maintenance of motor performances in mice treated with X protein was associated with better preservation of the neuromuscular junction compared to untreated SOD1G93A mice. \nIn addition\, the administration of X or XA4 proteins to SOD1G93A mice blocks the degeneration of phrenic motor neurons\, allowing them to return to values like the wild-type group. \nAlthough further investigations are needed to better understand the mechanisms involved in the effects of these proteins\, our work demonstrates their certain therapeutic effects\, on the extension of the life span\, on the preservation of the neuromuscular junction\, and the limitation of the degeneration of the spinal motor neurons. These studies open a new therapeutic avenue against ALS. \nKey words: amyotrophic lateral sclerosis; SOD1G93A mice; motor neuron degeneration; motor tests; life span \nJury\nM. RAOUL\, Cédric – Directeur de recherche-Université de Montpellier – INSERM U1051 – rapporteur \nMme BERTRAND\, Sandrine – Directrice de recherche-Université de BORDEAUX – examinatrice \nM. GOIZET\, Cyril – Praticien hospitalier – Bordeaux- examinateur \nMme CHEVALLIER\, Stéphanie – Maitre de conférences – Université Bordeaux – directrice de thèse \nM. LE MASSON Gwendal Professeur-Praticien hospitalier-Bordeaux-membre invité \nMembres invités :\n \nMme DA CRUZ\, Sandrine-Directrice de recherche- Leuven Brain Institute Belgique-examinatrice \nM. ROBITAILLE\, Richard-Directeur de recherche-Université de Montréal- rapporteur \n
URL:https://www.bordeaux-neurocampus.fr/en/event/thesis-defense-jeflie-tournezy/
CATEGORIES:Thesis
END:VEVENT
END:VCALENDAR